Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
Resource Type
Article
Authors
Berger, Michael ; Bromberg, Jacqueline ; Chen, Linda ; Dang, Chau ; Das, Jeeban P ; Drullinsky, Pamela ; Eng, Julianna ; Flynn, Jessica ; Gelblum, Daphna Y ; Gillespie, Erin F ; Girshman, Jeffrey ; Gomez, Daniel R ; Gucalp, Ayca ; Guttmann, David ; Hajj, Carla ; Higginson, Daniel ; Iqbal, Afsheen ; Khan, Atif J ; LaPlant, Quincey ; Lee, Nancy Y ; Mann, Justin M ; Modi, Shanu ; Namakydoust, Azadeh ; Ng, Kenneth ; Patel, Juber ; Powell, Simon N ; Preeshagul, Isabel ; Reis-Filho, Jorge S ; Reyngold, Marsha ; Riaz, Nadeem ; Rimner, Andreas ; Robson, Mark E ; Rudin, Charles M ; Sanford, Rachel ; Seidman, Andrew D ; Shah, Ronak ; Shaverdian, Narek ; Shepherd, Annemarie F ; Shin, Jacob Y ; Sugarman, Steven ; Traina, Tiffany A ; Tsai, Chiaojung Jillian ; Wu, Abraham J ; Xu, Amy J ; Yang, Jonathan T ; Yeh, Randy ; Zhang, Zhigang ; Zhi, Wanqing ; Eng, Juliana ; Seidman, Andrew ; Traina, Tiffany
Source
In The Lancet
Subject
Primary Research Articles
Language
ISSN
0140-6736